Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: Potential implications for pneumococcal conjugate vaccines

Vaccine

Volumn 27, Issue 29, 2009, Pages 3802-3810

  Rodgers, Gail L ^a   Arguedas, Adriano ^b   Cohen, Robert ^c   Dagan, Ron ^d  

^a PFIZER INC   (United States)

^b Instituto de Atencion Pediatrica Costa Rica   (Costa Rica)

^c CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Otitis media; Serotype; Streptococcus pneumoniae

Indexed keywords

ANTIBIOTIC AGENT; MACROLIDE; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ACUTE OTITIS MEDIA; ADOLESCENT; BACTERIAL COLONIZATION; CHILD; CLINICAL TRIAL; DRUG EFFECT; HUMAN; INCIDENCE; NASOPHARYNX; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; REVIEW; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; BACTERIAL TYPING TECHNIQUES; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 67349249343     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.04.021     Document Type: Review

References (96)

1. Centers for Disease Control and Prevention. Pneumococcal disease in children-Q&A. Available at: http://www.cdc.gov. Accessed February 7, 2008.
2. Teele D.W., Klein J.O., Rosner B., and Greater Boston Otitis Media Study Group. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis 160 (1989) 83-94
3. American Academy of Pediatrics and American Academy of Family Physicians. Clinical practice guideline: diagnosis and management of acute otitis media. Pediatrics 113 (2004) 1451-1465
4. Fischer T, Singer AJ, Lee C, Thode HC Jr. National trends in emergency department antibiotic prescribing for children with acute otitis media, 1996-2005. Acad Emerg Med 2007;14:1172-5.
5. Agency for Healthcare Research and Quality (AHRQ). Management of acute otitis media: evidence report/technology assessment number 15. Available at: http://www.ahrq.gov. Accessed August 8, 2008.
6. Jacobs M.R., Dagan R., Appelbaum P.C., and Burch D.J. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob Agents Chemother 42 (1998) 589-595
7. Del Beccaro M.A., Mendelman P.M., Inglis A.F., Richardson M.A., Duncan N.O., Clausen C.R., et al. Bacteriology of acute otitis media: a new perspective. J Pediatr 120 (1992) 81-84
8. Centers for Disease Control and Prevention. Pneumococcal disease. Epidemiology and prevention of vaccine-preventable diseases: the pinkbook. 10th ed. (2007), Centers for Disease Control and Prevention 257-270
9. Shouval D.S., Greenberg D., Givon-Lavi N., Porat N., and Dagan R. Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis. Pediatr Infect Dis J 25 (2006) 602-607
10. Hanage W.P., Auranen K., Syrjanen R., Herva E., Makela P.H., Kilpi T., et al. Ability of pneumococcal serotypes and clones to cause acute otitis media: implications for the prevention of otitis media by conjugate vaccines. Infect Immun 72 (2004) 76-81
11. Soley AC, Porat N, Loaiza C, Arguedas A, Dagan R. Detection of nasopharyngeal (NP) Streptococcus pneumoniae (Spn) serotypes prone to cause otitis media (OM). Presented at 46th International Conference of Antimicrobial Agents and Chemotherapy (ICAAC); September 27-30, 2006.
12. Eskola J., Kilpi T., Palmu A., Jokinen J., Haapakoski J., Herva E., et al., Finnish Otitis Media Study Group. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344 (2001) 403-409
13. Kilpi T., Ahman H., Jokinen J., Lankinen K.S., Palmu A., Savolainen H., et al., Finnish Otitis Media Study Group. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis 37 (2003) 1155-1164
14. Prymula R., Peeters P., Chrobok V., Kriz P., Novakova E., Kaliskova E., et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 367 (2006) 740-748
15. Expected benefits of pneumococcal vaccination in Canadian infants and children <5 years old. Can Commun Dis Rep 32 (2006) 45-56
16. Block S.L., Hedrick J., Harrison C.J., Tyler R., Smith A., Findlay R., et al. Pneumococcal serotypes from acute otitis media in rural Kentucky. Pediatr Infect Dis J 21 (2002) 859-865
17. Prevention of Pneumococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). No. RR-8. 4-4-1997. Washington, DC, Department of Health and Human Services, Centers for Disease Control. MMWR Morb Mortal Wkly Rep 46 RR-08 (1997) 1-24
18. Block S.L., Hedrick J., Harrison C.J., Tyler R., Smith A., Findlay R., et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 23 (2004) 829-833
19. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al., Northern California Kaiser Permanente Vaccine Study Center Group. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 19 (2000) 187-195
20. Fireman B., Black S.B., Shinefield H.R., Lee J., Lewis E., and Ray P. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J 22 (2003) 10-16
21. Cherry DK, Woodwell DA, Rechtsteiner EA, Division of Health Care Statistics. National Ambulatory Medical Care Survey: 2005 Summary. Hyattsville, MD: National Center for Health Statistics (CDC); 2007. p. 387.
22. Poehling K.A., Szilagyi P.G., Grijalva C.G., Martin S.W., LaFleur B., Mitchel E., et al. Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics 119 (2007) 707-715
23. Poehling K.A., Lafleur B.J., Szilagyi P.G., Edwards K.M., Mitchel E., Barth R., et al. Population-based impact of pneumococcal conjugate vaccine in young children. Pediatrics 114 (2004) 755-761
24. Grijalva C.G., Poehling K.A., Nuorti J.P., Zhu Y., Martin S.W., Edwards K.M., et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics 118 (2006) 865-873
25. Zhou F., Shefer A., Kong Y., and Nuorti J.P. Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004. Pediatrics 121 (2008) 253-260
26. Casey J.R., and Pichichero M.E. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J 23 (2004) 824-828
27. McEllistrem M.C., Adams J.M., Patel K., Mendelsohn A.B., Kaplan S.L., Bradley J.S., et al. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 40 (2005) 1738-1744
28. McEllistrem M.C., Adams J., Mason E.O., and Wald E.R. Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine. J Infect Dis 188 (2003) 1679-1684
29. Casey JR, Pichichero ME, Hoberman A, Schwartz R. Otopathogen distribution in the U.S. following introduction of the pneumococcal conjugate vaccine-7 valent (PCV7). Presented at 47th International Conference of Antimicrobial Agents and Chemotherapy (ICAAC); September 17-20, 2007.
30. Pichichero M.E., and Casey J.R. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA 298 (2007) 1772-1778
31. Morris P.S., Leach A.J., Silberberg P., Mellon G., Wilson C., Hamilton E., et al. Otitis media in young Aboriginal children from remote communities in Northern and Central Australia: a cross-sectional survey. BMC Pediatr 5 (2005) 27
32. Gibney K.B., Morris P.S., Carapetis J.R., Skull S.A., Smith-Vaughan H.C., Stubbs E., et al. The clinical course of acute otitis media in high-risk Australian Aboriginal children: a longitudinal study. BMC Pediatr 5 (2005) 16
33. Leach A.J. Otitis media in Australian Aboriginal children: an overview. Int J Pediatr Otorhinolaryngol 49 Suppl. 1 (1999) S173-S178
34. Morris P.S. A systematic review of clinical research addressing the prevalence, aetiology, diagnosis, prognosis and therapy of otitis media in Australian Aboriginal children. J Paediatr Child Health 34 (1998) 487-497
35. Hansman D. Serotypes in pneumococcal disease: a ten year study in Australia 1970 through 1979. Aust N Z J Med 13 (1983) 359-364
36. Watson M., Brett M., Brown M., Stewart M.G., Warren S., and New South Wales Pneumococcal Network. Pneumococci responsible for invasive disease and discharging ears in children in Sydney, Australia. J Med Microbiol 56 (2007) 819-823
37. Mackenzie GA, Carapetis JR, Leach AJ, Morris PS, Wigger C, Tipakalippa P. Pneumococcal vaccination and otitis media in Australian Aboriginal infants. Presented at 5th International Symposium on Pneumococci and Pneumococcal Diseases; March 2006.
38. Leach A, Beissbarth J, Halpin S, Hare K, Kennedy M, Mackenzie G, et al. Microbiology of acute otitis media with perforation (AOMwiP) in Aboriginal children living in remote communities-monitoring the impact of 7-valent pneumococcal conjugate vaccine (7vPCV). Presented at 5th International Symposium on Pneumococci and Pneumococcal Diseases; March 2006.
39. Marsh R.L., Smith-Vaughan H., Beissbarth J., Hare K., Kennedy M., Wigger C., et al. Molecular characterisation of pneumococcal serotype 16F: established predominant carriage and otitis media serotype in the 7vPCV era. Vaccine 25 (2007) 2434-2436
40. Ess S.M., Schaad U.B., Gervaix A., Pinosch S., and Szucs T.D. Cost-effectiveness of a pneumococcal conjugate immunisation program for infants in Switzerland. Vaccine 21 (2003) 3273-3281
41. Kilpi T., Herva E., Kaijalainen T., Syrjanen R., and Takala A.K. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J 20 (2001) 654-662
42. Ziebold C., von Kries R., Siedler A., and Schmitt H.J. Epidemiology of pneumococcal disease in children in Germany. Acta Paediatr Suppl 435 (2000) 17-21
43. Gene A., Garcia-Garcia J.J., Domingo A., Wienberg P., and Palacin E. Etiology of acute otitis media in a children's hospital and sensitivity of the involved microorganisms to antibiotics [in Spanish]. Enferm Infecc Microbiol Clin 22 (2004) 377-380
44. Husson M.O., Pierreti A., Quelquejay J., Vaneecloo F.M., Courcol R.J., and Vincent C. Bacterial epidemiological study of acute otitis media in infants observed at home [locally] in the Nord Pas-de-Calais area [in French]. Pathol Biol (Paris) 49 (2001) 789-793
45. del Castillo F., Barrio Gomez M.I., and Garcia A. Bacteriologic study of 80 cases of acute otitis media in children [in Spanish]. Enferm Infecc Microbiol Clin 12 (1994) 82-85
46. Kouppari G., Zaphiropoulou A., Stamos G., Deliyianni V., Apostolopoulos N., and Legakis N.J. Pneumococcal acute otitis media in children. Clin Microbiol Infect 6 (2000) 69-73
47. Palmu A.A.I., Jokinen J.T., Kaijalainen T., Leinonen M., Karma P., and Kilpi T.M. Association of clinical signs and symptoms with pneumococcal acute otitis media by serotype-implications for vaccine effect. Clin Infect Dis 40 (2005) 52-57
48. Fenoll A., Jado I., Vicioso D., Berron S., Yuste J.E., and Casal J. Streptococcus pneumoniae in children in Spain: 1990-1999. Acta Paediatr Suppl 435 (2000) 44-50
49. Canton E., Montaner M., Perez-Belles C., Roman J., Moreno R., Igual R., et al. Serotypes and antibiotic susceptibility of Streptococcus pneumoniae in children in the health district of Valencia and Castellon, Spain: a multicenter prospective trial [in Spanish]. Rev Esp Quimioter 16 (2003) 412-420
50. Demachy M.-C., Faibis F., Artigou A., Benoit C., Cambau E., Cecille A., et al. Epidemiology and antimicrobial [antibiotic] resistance of Streptococcus pneumoniae strains isolated in Ile-de-France in 2001 [in French]. Med Mal Infect 34 (2004) 303-309
51. Zissis N.P., Syriopoulou V., Kafetzis D., Daikos G.L., Tsilimingaki A., Galanakis E., et al. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive infections and acute otitis media in children. Eur J Pediatr 163 (2004) 364-368
52. Kouppari G., Zaphiropoulou A., Tsolia M., Apostolopoulos N., Deliyianni V., and Kafetzis D. Serotyping and antibiotic resistance of Streptococcus pneumoniae isolated from pediatric infections in central Greece. Clin Microbiol Infect 4 (1998) 695-700
53. Prymula R., Motlova J., and Kriz P. Comparison of Streptococcus pneumoniae serotypes causing acute otitis media & invasive disease in young children in the Czech Republic. Indian J Med Res 119 Suppl (2004) 168-170
54. Levidiotou S., Vrioni G., Tzanakaki G., Pappa C., Gesouli H., Gartzonika C., et al. Serotype distribution of Streptococcus pneumoniae in north-western Greece and implications for a vaccination programme. FEMS Immunol Med Microbiol 48 (2006) 179-182
55. van Kempen M.J.P., Vaneechoutte M., Claeys G., Verschraegen G.L.C., Vermeiren J., and Dhooge I.J. Antibiotic susceptibility of acute otitis media pathogens in otitis-prone Belgian children. Eur J Pediatr 163 (2004) 524-529
56. Reichler M.R., Rakovsky J., Sobotova A., Slacikova M., Hlavacova B., Hill B., et al. Multiple antimicrobial resistance of pneumococci in children with otitis media, bacteremia, and meningitis in Slovakia. J Infect Dis 171 (1995) 1491-1496
57. Nissinen A., Leinonen M., Huovinen P., Herva E., Katila M.-L., Kontiainen S., et al. Antimicrobial resistance of Streptococcus pneumoniae in Finland, 1987-1990. Clin Infect Dis 20 (1995) 1275-1280
58. Palmu A.A.I., Verho J., Jokinen J., Karma P., and Kilpi T.M. The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children. Pediatr Infect Dis J 23 (2004) 732-738
59. Adam D, Helmerking MWO. Prevention of acute otitis media (AOM) in children <2 years of age: incidence and impact of environmental risk factors and effectiveness of pneumococcal conjugate vaccine (PCV7). Presented at 46th International Conference of Antimicrobial Agents and Chemotherapy (ICAAC); September 27-30, 2006.
60. Esposito S., Lizioli A., Lastrico A., Begliatti E., Rognoni A., Tagliabue C., et al. Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age. Respir Res 8 (2007) 12
61. van Kempen M.J.P., Vermeiren J.S., Vaneechoutte M., Claeys G., Veenhoven R.H., Rijkers G.T., et al. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?. Int J Pediatr Otorhinolaryngol 70 (2006) 275-285
62. Veenhoven R., Bogaert D., Uiterwaal C., Brouwer C., Kiezebrink H., Bruin J., et al. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet 361 (2003) 2189-2195
63. van Heerbeek N., Straetemans M., Wiertsema S.P., Ingels K.J.A.O., Rijkers G.T., Schilder A.G.M., et al. Effect of combined pneumococcal conjugate and polysaccharide vaccination on recurrent otitis media with effusion. Pediatrics 117 (2006) 603-608
64. Arevalo-Silva C.A., Villasenor-Sierra A., Kuri-Morales P., Tapia-Conyer R., and Santos-Preciado J.I. Acute otitis media in Mexico: cases reported during the period from 1995 to 1998 [in Spanish]. Gac Med Mex 135 (1999) 541-543
65. Arguedas A., Dagan R., Soley C., Loaiza C., Knudsen K., Porat N., et al. Microbiology of otitis media in Costa Rican children, 1999 through 2001. Pediatr Infect Dis J 22 (2003) 1063-1068
66. Arguedas A., Loaiza C., Perez A., Vargas F., Herrera M., Rodríguez G., et al. Microbiology of acute otitis media in Costa Rican children. Pediatr Infect Dis J 17 (1998) 680-689
67. Rosenblut A., Santolaya M.E., Gonzalez P., Corbalan V., Avendano L.F., Martinez M.A., et al. Bacterial and viral etiology of acute otitis media in Chilean children. Pediatr Infect Dis J 20 (2001) 501-507
68. Rosenblut A., Santolaya M.E., Gonzalez P., Borel C., and Cofre J. Penicillin resistance is not extrapolable to amoxicillin resistance in Streptococcus pneumoniae isolated from middle ear fluid in children with acute otitis media. Ann Otol Rhinol Laryngol 115 (2006) 186-190
69. Alvarado O, Aguilar L, Soley C, Loaiza C, Guevara S, Rincon G, et al. Microbiology of otitis media in Costa Rican children between 2002-2007. Presented at 47th International Conference of Antimicrobial Agents and Chemotherapy (ICAAC); September 17-20, 2007.
70. Arguedas A., Dagan R., Guevara S., Porat N., Soley C., Perez A., et al. Middle ear fluid Streptococcus pneumoniae serotype distribution in Costa Rican children with otitis media. Pediatr Infect Dis J 24 (2005) 631-634
71. Hausdorff W.P., Yothers G., Dagan R., Kilpi T., Pelton S.E., Cohen R., et al. Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J 21 (2002) 1008-1016
72. Gomez-Barreto D., Rodriguez R.S., Calderon Jaimes E., and Espinoza L.E. Physiopathological bases for preventing infections from Streptococcus pneumoniae [in Spanish]. Boletin Medico del Hospital Infantil de Mexico 58 (2001) 866-878
73. Arguedas A, Porat N, Soley A, Dagan R. Importance of serotype 3 and 14 S. pneumoniae (Spn) isolates in Costa Rican children with otitis media (OM). Presented at 46th International Conference of Antimicrobial Agents and Chemotherapy (ICAAC); September 27-30, 2006.
74. Abdelnour A, Soley C, Porat N, Dagan R, Arguedas A. Streptococcus pneumoniae (Spn) serotype 3 otitis media (OM) in Costa Rican (CR) children: clinical, epidemiological characteristics and antimicrobal resistance patterns. Presented at 47th International Conference of Antimicrobial Agents and Chemotherapy (ICAAC); September 17-20, 2007.
75. Guevara S, Soley C, Porat N, Dagan R, Arguedas A. Prevalence of Streptococcus pneumoniae (Spn) serotypes in Costa Rican (CR) children (CH) with otitis media (OM) according to diagnosis, demographics and seasonality between 2002-2005. Presented at 47th International Conference of Antimicrobial Agents and Chemotherapy (ICAAC); September 17-20, 2007.
76. Lopez-Enriquez C, Espinosa-Monteros LE, Rojas L, Gomez-Barreto D. Middle ear fluid Streptococcus pneumoniae serotype distribution and antimicrobial susceptibility patterns in Mexican children with acute otitis media. Presented at 5th International Symposium on Pneumococci and Pneumococcal Diseases; March 2006.
77. Sih T.M. Acute otitis media in Brazilian children: analysis of microbiology and antimicrobial susceptibility. Ann Otol Rhinol Laryngol 110 (2001) 662-666
78. Dagan R., Givon-Lavi N., Shkolnik L., Yagupsky P., and Fraser D. Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: implication for immunizing with conjugate vaccines. J Infect Dis 181 (2000) 1322-1329
79. Porat N., Barkai G., Jacobs M.R., Trefler R., and Dagan R. Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel. J Infect Dis 189 (2004) 385-392
80. Dagan R, Givon-Lavi N, Leibovitz E, Porat N. Increased importance of antibiotic-resistant (AR) S. pneumoniae serotype 19A (Pn19A) in acute otitis media (AOM) occurring before introduction of 7-valent pneumococcal conjugate vaccine (PCV7) in Southern Israel. Presented at 47th International Conference of Antimicrobial Agents and Chemotherapy (ICAAC); September 17-20, 2007.
81. Shouval D.S., Greenberg D., Givon-Lavi N., Porat N., and Dagan R. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines. Pediatr Infect Dis J 28 (2009) 277-282
82. Kamiya H., Kato T., Togashi T., Iwata S., Kurosaki T., Baba S., et al. Epidemiological survey of pneumococcus serotypes in pediatric patients with acute suppurative otitis media [in Japanese]. Kansenshogaku Zasshi 81 (2007) 59-66
83. Ubukata K., Kobayashi R., Chiba N., Hasegawa K., and Konno M. Surveillance based on molecular epidemiology for Streptococcus pneumoniae isolates between 1998 and 2000 in Japan [in Japanese]. Jpn J Chemother 51 (2003) 60-70
84. Amusa Y.B., Ijadunola I.K.T., and Onayade O.O. Epidemiology of otitis media in a local tropical African population. West Afr J Med 24 (2005) 227-230
85. Huebner R.E., Wasas A.D., Hockman M., Klugman K.P., and ENT Study Group. Bacterial aetiology of non-resolving otitis media in South African children. J Laryngol Otol 117 (2003) 169-172
86. Klein J.O. Microbiologic efficacy of antibacterial drugs for acute otitis media. Pediatr Infect Dis J 12 (1993) 973-975
87. Leibovitz E, Serebro M, Givon-Lavi N, Leiberman A, Dagan R. Epidemiologic and microbiologic characteristics of culture-positive spontaneous otorrhea (SO) in children with acute otitis media (AOM). Presented at 47th International Conference of Antimicrobial Agents and Chemotherapy (ICAAC); September 17-20, 2007.
88. Porat N., Soley C., Marengolciene M.M., Greenberg D., Givon-Lavi N., Trefler R., et al. An international serotype 3 clone causing pediatric noninvasive infections in Israel, Costa Rica, and Lithuania. Pediatr Infect Dis J 27 (2008) 709-712
89. Pai R., Moore M.R., Pilishvili T., Gertz R.E., Whitney C.G., Beall B., and Active Bacterial Core Surveillance Team. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis 192 (2005) 1988-1995
90. Singleton R.J., Hennessy T.W., Bulkow L.R., Hammitt L.L., Zulz T., Hurlburt D.A., et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297 (2007) 1784-1792
91. Huang S.S., Platt R., Rifas-Shiman S.L., Pelton S.I., Goldmann D., and Finkelstein J.A. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 116 (2005) e408-e413
92. Pelton S.I., Huot H., Finkelstein J.A., Bishop C.J., Hsu K.K., Kellenberg J., et al. Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J 26 (2007) 468-472
93. Messina A.F., Katz-Gaynor K., Barton T., Ahmad N., Ghaffar F., Rasko D., et al. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Pediatr Infect Dis J 26 (2007) 461-467
94. Beall B. Vaccination with the pneumococcal 7-valent conjugate: a successful experiment but the species is adapting. Expert Rev Vaccines 6 (2007) 297-300
95. Hicks L.A., Harrison L.H., Flannery B., Hadler J.L., Schaffner W., Craig A.S., et al., Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 196 (2007) 1346-1354
96. Kim N-H, Kim S-H, Lee J-A, Choi E-H, Lee H-J. Changes of serotype distribution of Streptococcus pneumoniae isolated from children in Korea over a 15 year-period, 1991-2005. Presented at 44th Annual Meeting of IDSA; October 12-15, 2006.